Jean-François Formela, M.D.

Dr. Jean-Francois Formela is a partner at Atlas Venture, where he focuses on new advances in biology and drug discovery technologies as well as novel therapeutics. He is chairman of IFM Therapeutics and serves on the boards of Intellia Therapeutics (NASDAQ: NTLA), F-star, Kyn Therapeutics, Spero Therapeutics (NASDAQ: SPRO), and . . .